ALLERGAN - Trademark Details
Status: 700 - Registered
Serial Number
86983196
Registration Number
5443889
Word Mark
ALLERGAN
Status
700 - Registered
Status Date
2018-04-10
Filing Date
2015-06-12
Registration Number
5443889
Registration Date
2018-04-10
Mark Drawing
3000 - Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s)
Typeset
Design Searches
010107, 260121, 260131, 290303, 290306, 290603, 290606 - Stars with tails or comets. Circles that are totally or partially shaded. Five or more circles. Single color used on a portion of the goods or on a portion of items used in rendering the services: Blue. Single color used on a portion of the goods or on a portion of items used in rendering the services: Green. Multiple colors used on a portion of the goods or on a portion of the items used in rendering the services: Blue. Multiple colors used on a portion of the goods or on a portion of the items used in rendering the services: Green.
Published for Opposition Date
2016-03-01
Law Office Assigned Location Code
L90
Employee Name
MARESCA, MEREDITH Z
Statements
Indication of Colors claimed
The color(s) dark blue, medium blue, light blue, green, medium green, and yellow is/are claimed as a feature of the mark.
Description of Mark
The mark consists of the word "ALLERGAN" in a stylized dark blue font to the left of which is a stylized futuristic comet design comprised of circles that are as follows moving from right to left: three large dark blue circles, followed next by four medium blue circles that are large on the outside with the two middle circles being smaller, followed next by three small light blue circles, followed next by three large green circles, followed next by three smaller medium green circles, followed next by three small yellow circles, with the last circle being the point of the comet.
Goods and Services
House mark used for a line of pharmaceuticals used in connection with anti-aging, the treatment of glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin, facial aesthetic surgery, facial aesthetic reconstruction, breast aesthetics; topical antibiotics, anti-inflammatory, anti-infective, anti-glaucoma and decongestant formulations, and pharmaceutical preparations to treat and prevent glaucoma; ocular wetting solutions, namely, eye drops, artificial tears and gels for the treatment of minor ocular inflammations and allergic conditions; Pharmaceutical preparations for the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, hyperhydrosis, sports injuries, cerebral palsy, spasms, tremors and pain; dermatological formulations, namely, medicated dry skin lotions and creams, acne medications and medicated skin lighteners; Oral, transdermal, injectable and intravaginal contraceptive preparations; intravaginal contraceptive sponge; Hormone replacement therapy preparations; Pharmaceutical preparations for the prevention of preterm birth or pregnancy; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations for the treatment and prevention of endometriosis; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Iron chelating pharmaceutical preparations; Fertility enhancing preparations; Pharmaceuticals and medicines for the treatment and prevention of sexual dysfunction; Pharmaceuticals and medicines for the prevention and treatment of conditions affecting sensory organs; Pharmaceuticals and medicines for the prevention and treatment of conditions affecting the central nervous system; Pharmaceuticals and medicines for the prevention and treatment of conditions affecting urogenital organs; Pharmaceuticals and medicines for the prevention and treatment of conditions affecting circulatory systems; Pharmaceuticals and medicines for the treatment of cardiovascular disease and blood pressure; Pharmaceutical preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceuticals and medicines for the treatment and prevention of irritable bowel syndrome; Pharmaceutical preparations that support, encourage or promote bone strength or bone health or which are used in the treatment of bone disorders or bone diseases; Antibiotics; Antifungal preparations; Antivirals and Antiprotozoals; Pharmaceutical preparations for the prevention and treatment of bacterial infections; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of hypertension; Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease, dementia, AIDS-related dementia, central nervous system disorders, neurological disorders, neurodegenerative disorders, and depression, neuroprotective agent; antidepressants; pharmaceuticals, namely, antipsychotics; coronary vasodilating agents; Pharmaceutical preparations for the treatment of hypothyroidism; Pharmaceuticals and cosmeceuticals, namely, medicated skin cleansers, toners, moisturizers, rejuvenators, rehydrating creams, and lotions for the face and body; medicated cosmetic skin care preparations
Goods and Services
House mark used for a line of surgical, medical, dental and veterinary apparatus and instruments, namely, diagnostic test kits principally composed of medical diagnostic meters that measure conditions of the cardio-vascular and immune systems; intra-uterine non-chemical contraceptive devices; medical diagnostic instruments for the analysis of body fluids; medical devices for treating glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin, and for use in facial aesthetic surgery, facial aesthetic reconstruction, breast aesthetics and ophthalmic related diseases and disorders
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2015-06-17
Primary Code
005
First Use Anywhere Date
2017-06-30
First Use In Commerce Date
2017-06-30
International Class
010 - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth; orthopedic articles; suture materials. - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth; orthopedic articles; suture materials.
US Class Codes
026, 039, 044
Class Status Code
6 - Active
Class Status Date
2015-06-17
Primary Code
010
First Use Anywhere Date
2016-10-12
First Use In Commerce Date
2016-10-12
Current Trademark Owners
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
10 - Original Applicant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Correspondences
Name
SUSAN J. HINCHEY
Address
Please log in with your Justia account to see this address.
Prior Registrations
| Relationship Type | Reel Number |
| Prior Registration | 2147765 |
| Prior Registration | 3332859 |
| Prior Registration | 3596709 |
| Continuity Parent | 86661138 |
Trademark Events
| Event Date | Event Description |
| 2015-06-16 | NEW APPLICATION ENTERED IN TRAM |
| 2015-06-17 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| 2015-06-18 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| 2015-09-22 | ASSIGNED TO EXAMINER |
| 2015-09-22 | PRIORITY ACTION WRITTEN |
| 2015-09-22 | PRIORITY ACTION E-MAILED |
| 2015-09-22 | NOTIFICATION OF PRIORITY ACTION E-MAILED |
| 2016-01-19 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 2016-01-19 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2016-01-20 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 2016-01-22 | EXAMINERS AMENDMENT -WRITTEN |
| 2016-01-22 | EXAMINERS AMENDMENT E-MAILED |
| 2016-01-22 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| 2016-01-22 | EXAMINER'S AMENDMENT ENTERED |
| 2016-01-22 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 2016-02-10 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 2016-03-01 | PUBLISHED FOR OPPOSITION |
| 2016-03-01 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 2016-04-26 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 2016-09-14 | TEAS EXTENSION RECEIVED |
| 2016-09-14 | EXTENSION 1 FILED |
| 2016-09-14 | EXTENSION 1 GRANTED |
| 2016-09-16 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 2017-03-24 | TEAS EXTENSION RECEIVED |
| 2017-03-24 | EXTENSION 2 FILED |
| 2017-03-24 | EXTENSION 2 GRANTED |
| 2017-03-28 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 2017-09-20 | TEAS STATEMENT OF USE RECEIVED |
| 2017-09-20 | TEAS REQUEST TO DIVIDE RECEIVED |
| 2017-09-28 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 2017-09-20 | DIVISIONAL REQUEST RECEIVED |
| 2017-09-28 | DIVISIONAL PROCESSING COMPLETE |
| 2017-09-20 | USE AMENDMENT FILED |
| 2017-09-28 | STATEMENT OF USE PROCESSING COMPLETE |
| 2017-09-29 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| 2017-10-04 | SU - NON-FINAL ACTION - WRITTEN |
| 2017-10-04 | NON-FINAL ACTION E-MAILED |
| 2017-10-04 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 2017-10-10 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 2017-10-24 | ASSIGNED TO LIE |
| 2017-10-25 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2017-10-25 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 2017-10-27 | SU - FINAL REFUSAL - WRITTEN |
| 2017-10-27 | FINAL REFUSAL E-MAILED |
| 2017-10-27 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| 2018-02-08 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| 2018-02-09 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2018-02-09 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 2018-03-02 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 2018-03-03 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 2018-04-10 | REGISTERED-PRINCIPAL REGISTER |
